CCK - cholecystokinin Gene

Species: Felis catus

Gene Type: protein coding
Gene ID: 101096837

CCK Products (1)

mRNA Protein Name
XM_003992210.6 XP_003992259.1 cholecystokinin
Protein Preferred Names Protein Names

cholecystokinin

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (5)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P0093 Sincalide 99.30% Unkown
HY-B1330 Proglumide Antagonist 99.84% Yes
HY-P0093A Sincalide ammonium 99.21% Unkown
HY-103354 Proglumide sodium Antagonist 99.58% Yes
HY-103354A Proglumide hemicalcium Antagonist / Unkown

Clinical Phase

Bioactive Molecules (10)
Cat. No. Product Name Effect
Purity Phase
HY-128878 Dexloxiglumide Antagonist 98.25% Phase 3
HY-19445 Gastrazole Antagonist / Phase 3
HY-106840 L-365260 Antagonist 99.85% Phase 2
HY-14850 Sograzepide Antagonist 98.04% Phase 2
HY-101764 Lintitript Antagonist 99.58% Phase 2
HY-17617 Nastorazepide 99.95% Phase 2
HY-105257 Pranazepide Antagonist 99.81% Phase 2
HY-106356 GV-150013 Antagonist / Phase 2
HY-11074 CE-326597 Agonist / Phase 2
HY-19261 T-0632 Antagonist 99.88% Phase 1

Pre-clinical Phase

Bioactive Molecules (96)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P1097 Gastrin I, human 99.93% Unkown
HY-P2671 [Leu15]-Gastrin I (human) 99.98% Unkown
HY-106301 Devazepide Antagonist 99.55% Unkown
HY-103355 YM022 Antagonist 99.87% Unkown
HY-P2932 Cholecystokinin 98.16% Unkown
HY-125556 Tetragastrin Agonist 99.89% Unkown
HY-P0196 Cholecystokinin Octapeptide, desulfated 99.45% Unkown
HY-B1439B Lorglumide sodium Antagonist 99.19% Unkown
HY-P1096 A71623 Agonist 99.34% Unkown
HY-107759 Butabindide oxalate Inhibitor 98.98% Unkown
HY-B2154 Loxiglumide Antagonist 98.0% Unkown
HY-111313 JNJ-26070109 Antagonist 99.25% Unkown
HY-124187 Pinolenic acid ethyl ester ≥98.0% Unkown
HY-101352 LY 225910 Antagonist 98.92% Unkown
HY-106840A L-365260 hemihydrate Antagonist 99.75% Unkown
HY-118194 A-65186 Antagonist 99.94% Unkown
HY-148656 PNB-001 Antagonist 99.65% Unkown
HY-U00360 (Rac)-Sograzepide Antagonist 98.98% Unkown
HY-105226B CI-988 hemihydrate Antagonist ≥99.0% Unkown
HY-129357 CCK-B Receptor Antagonist 2 Inhibitor 98.84% Unkown
HY-155205 GV150013X Antagonist 99.75% Unkown
HY-169914 Igmesine hydrochloride / Unkown
HY-P0196A Cholecystokinin Octapeptide, desulfated TFA 97.17% Unkown
HY-P2636 Cholecystokinin Precursor (24-32) (rat) 99.54% Unkown
HY-P2677 CCK (26-31) sulfated 96.38% Unkown
HY-P2932A Cholecystokinin-33 free acid 95.77% Unkown
HY-P3704 Enterostatin (rat) 98.16% Unkown
HY-125314 AG-041R Antagonist 99.9% Unkown
HY-U00062 Tarazepide Antagonist / Unkown
HY-100481 RP 72540 Antagonist / Unkown
HY-103279 BIM187 Agonist / Unkown
HY-103357 LY288513 Antagonist / Unkown
HY-103357A LY262691 Antagonist / Unkown
HY-105226 CI-988 Antagonist / Unkown
HY-105226A CI-988 meglumin Antagonist / Unkown
HY-105955 FPL 14294 / Unkown
HY-109028 Ceclazepide / Unkown
HY-111918 A71378 Agonist / Unkown
HY-113896 U-67827E Agonist / Unkown
HY-116260 RP-69758 Antagonist / Unkown
HY-117781 GW-5823 Agonist / Unkown
HY-117828 PF-04756956 Inhibitor / Unkown
HY-117839 PD-135666 Inhibitor / Unkown
HY-118314 CI-1015 / Unkown
HY-118546 JNJ-17156516 Antagonist / Unkown
HY-120381 PD 136450 Antagonist / Unkown
HY-121278 Benzotript Antagonist / Unkown
HY-125431 LY 202769 Antagonist / Unkown
HY-128941 CCK2R Ligand-Linker Conjugates 1 / Unkown
HY-14575 Nastorazepide hemicalcium / Unkown
HY-150070 Butabindide Inhibitor / Unkown
HY-164634 CLIK-148 Inhibitor / Unkown
HY-172281 DSPE-PEG1000-CCK8 / Unkown
HY-172281A DSPE-PEG2000-CCK8 / Unkown
HY-172281B DSPE-PEG5000-CCK8 / Unkown
HY-177506 FE100726 Agonist / Unkown
HY-177507 FE101120 Agonist / Unkown
HY-177508 BC264 Agonist / Unkown
HY-177509 BBL454 Agonist / Unkown
HY-186122 CCK2R agonist-1 Agonist / Unkown
HY-B1439 Lorglumide Antagonist / Unkown
HY-P1133 Galanin (2-29) (rat) Agonist / Unkown
HY-P1710 ARL 15849XX Agonist / Unkown
HY-P1800 Caerulein, desulfated Control / Unkown
HY-P1988 JMV 179 Antagonist / Unkown
HY-P1994A JMV 170 Agonist / Unkown
HY-P2025 JMV 236 / Unkown
HY-P2055 A-57696 / Unkown
HY-P2121 JMV 176 Agonist / Unkown
HY-P2165 N-acetyl CCK-(26-30) amide Antagonist / Unkown
HY-P2424 Cholecystokinin-J / Unkown
HY-P2592 Ro 23-7014 / Unkown
HY-P2627 CCK (27-33) / Unkown
HY-P2638 Cholecystokinin (27-32)-amide Antagonist / Unkown
HY-P2678 CCK (26-31) non-sulfated Agonist / Unkown
HY-P3650 Cholecystokinin (1-21) / Unkown
HY-P3652 Cholecystokinin-33 (swine) Agonist / Unkown
HY-P5526 CCK1-specific peptide substrate / Unkown
HY-RS02073 CCK Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS11995 RIPK2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS11996 Ripk2 Mouse Pre-designed siRNA Set A / Unkown
HY-U00363 CHEMBL333994 Antagonist / Unkown
HY-U00363A (rac)-CHEMBL333994 Control / Unkown
HY-116576 LY219057 Antagonist / Unkown
HY-118665 L-736380 Antagonist / Unkown
HY-118904 VL-0395 Antagonist / Unkown
HY-123434 PD-149164 Agonist / Unkown
HY-125610 DA-3934 Antagonist / Unkown
HY-129516 A-70874 Agonist / Unkown
HY-129759 KSG-504 anhydrous Inhibitor / Unkown
HY-162070 CCK antagonist 1 Antagonist 99.96% Unkown
HY-B1439BR Lorglumide sodium (Standard) Antagonist / Unkown
HY-RS16534 Cck Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS22965 Cck Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-U00375 Gastrin/CCK antagonist 1 Antagonist / Unkown
HY-U00387 CCK-A receptor inhibitor 1 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens CCK NCBI NCBI:885